Pharmacy
Despite recent attention to rising pharmaceutical prices, a new study claims the total costs of treating patients with cancer in the United States have risen no faster than overall costs for Medicare and commercial insurance in the past decade.
When California's aid-in-dying law takes effect this June, terminally ill patients who decide to end their lives could be faced with a hefty bill for the lethal medication. It retails for more than $3,000.
Healthcare Supply Chain Association President and CEO Todd Ebert has praised the U.S. Food and Drug Administration's decision to prioritize abbreviated new drug applications for generic drugs with only one manufacturer, sometimes known as "sole source" products.
Valeant Pharmaceuticals International is now searching for a new chief executive officer, having told current CEO Mike Pearson over the weekend that he is no longer in the company's long-term plans. Pearson will continue to serve as CEO and a director until his replacement is appointed.
Not only does a hospital collect more revenue from patients by allowing them to fill their prescriptions on-site, but evidence suggests that this approach cuts down on readmissions, further helping health systems save money.
Rising prices and big-dollar medications are leading to increases in prescription drug spending, the Department of Health and Human Services has found.
Most of the people running for president say they want to do something about the rising cost of prescription drugs. But most of their proposals probably won't work because they don't address the dynamics behind these price increases.
Medicare beneficiaries who live in urban areas may save money on their prescription drugs this year because they have better access to pharmacies in drug plan networks that charge lower copayments or coinsurance, according to the federal Centers for Medicare & Medicaid Services.
Prescription drug spending in the U.S. rose 12 percent in 2014, reaching nearly $300 billion, the latest issue of the Journal of Managed Care and Specialty Pharmacy showed.
While the medical importance of vaccines is largely known, a pair of researchers is looking to define just what economic value vaccines play in the realm of global healthcare.